- Home
- ADAP vs CIO Comparison
ADAP vs CIO Comparison
Compare ADAP & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CIO
- Stock Information
- Founded
- ADAP 2008
- CIO 2013
- Country
- ADAP United Kingdom
- CIO Canada
- Employees
- ADAP N/A
- CIO N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CIO Real Estate Investment Trusts
- Sector
- ADAP Health Care
- CIO Real Estate
- Exchange
- ADAP Nasdaq
- CIO Nasdaq
- Market Cap
- ADAP 212.3M
- CIO 230.9M
- IPO Year
- ADAP 2015
- CIO 2014
- Fundamental
- Price
- ADAP $0.62
- CIO $5.66
- Analyst Decision
- ADAP Strong Buy
- CIO
- Analyst Count
- ADAP 4
- CIO 0
- Target Price
- ADAP $2.79
- CIO N/A
- AVG Volume (30 Days)
- ADAP 2.3M
- CIO 378.8K
- Earning Date
- ADAP 11-13-2024
- CIO 10-31-2024
- Dividend Yield
- ADAP N/A
- CIO 7.11%
- EPS Growth
- ADAP N/A
- CIO N/A
- EPS
- ADAP N/A
- CIO N/A
- Revenue
- ADAP $175,041,000.00
- CIO $173,528,000.00
- Revenue This Year
- ADAP $204.91
- CIO N/A
- Revenue Next Year
- ADAP N/A
- CIO $0.90
- P/E Ratio
- ADAP N/A
- CIO N/A
- Revenue Growth
- ADAP 146.27
- CIO N/A
- 52 Week Low
- ADAP $0.43
- CIO $4.02
- 52 Week High
- ADAP $2.05
- CIO $6.63
- Technical
- Relative Strength Index (RSI)
- ADAP 37.29
- CIO 54.19
- Support Level
- ADAP $0.57
- CIO $5.58
- Resistance Level
- ADAP $0.61
- CIO $5.87
- Average True Range (ATR)
- ADAP 0.04
- CIO 0.16
- MACD
- ADAP -0.00
- CIO 0.00
- Stochastic Oscillator
- ADAP 27.46
- CIO 46.84
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.